Literature DB >> 33881669

Comparison of vitamin D levels between patients with pterygium and healthy subjects.

Şemsettin Bilak1, Sedat Yılmaz2, Burak Bilgin3.   

Abstract

PURPOSE: The purpose of this study was to compare vitamin D (VD) deficiency frequency among patients with pterygium to that of healthy subjects and to investigate the VD deficiency among patients with pterygium.
METHODS: One-hundred eight pterygium patients and 94 healthy subjects were included in the study. Blood samples were collected from groups during the same time interval and the samples were saved. Serum 25-hydroxyvitamin D (25(OH)D) and parathormone (PTH) levels were measured and analyzed.
RESULTS: The pterygium group consisted of 57 female and 51 male patients, while the control group consisted of 47 female and 47 male patients. The mean age, sex and mean BMI were similar in the two groups (p > 0.05). The percentage of time that individuals spent outdoors was higher in the pterygium group (p = 0.02). The percentage of VD deficiency was 83.3% in the pterygium group and 61.7% in the control group (p = 0.001). There was a positive correlation between VD and time spent outdoors (p < 0.05).
CONCLUSIONS: VD deficiency can play a role in pterygium etiopathogenesis. Wide population-based studies in different regions are needed to evaluate this result.

Entities:  

Keywords:  Parathormone; Pterygium; Vitamin D

Year:  2021        PMID: 33881669     DOI: 10.1007/s10792-021-01868-0

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  2 in total

1.  Effects of 1alpha,25-dihydroxyvitamin D3 on Langerhans cell migration and corneal neovascularization in mice.

Authors:  T Suzuki; Y Sano; S Kinoshita
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-01       Impact factor: 4.799

2.  UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells.

Authors:  Nick Di Girolamo; Rakesh K Kumar; Minas T Coroneo; Denis Wakefield
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-11       Impact factor: 4.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.